211
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Serum Levels and H/L Gene Polymorphism of Mannose-Binding Lectin in Primary Open Angle Glaucoma

, , &
Pages 212-217 | Received 21 Jul 2011, Accepted 04 Nov 2011, Published online: 15 Feb 2012

REFERENCES

  • Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097–1106.
  • Allingham RR, Liu Y, Rhee DJ. The genetics of primary open-angle glaucoma: A review. Exp Eye Res. 2009;88:837–844.
  • Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med. 2009;360:1113–1124.
  • Schwartz M. Lessons for glaucoma from other neurodegenerative diseases: Can one treatment suit them all? J Glaucoma. 2005;14:321–323.
  • Murakami A, Okisaka S. [Neuronal cell death mechanism in glaucomatous optic neuropathy]. Nippon Ganka Gakkai Zasshi. 1998;102:645–653.
  • Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 1997;115:497–503.
  • Wax MB. Is there a role for the immune system in glaucomatous optic neuropathy? Curr Opin Ophthalmol. 2000;11:145–150.
  • Tezel G, Seigel GM, Wax MB. Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci. 1998;39:2277–2287.
  • Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N. Complex autoantibody repertoires in patients with glaucoma. Mol Vis. 2004;10:132–137.
  • Joachim SC, Pfeiffer N, Grus FH. Autoantibodies in patients with glaucoma: A comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol. 2005;243:817–823.
  • Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: Clinical implications for infection, transplantation, and autoimmunity. Hum Immunol. 2006;67:247–256.
  • Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol. 2003;40:423–429.
  • Zundel S, Cseh S, Lacroix M et al. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2. J Immunol. 2004;172:4342–4350.
  • Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol. 2000;165:2637–2642.
  • Super M, Gillies SD, Foley S et al. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet. 1992;2:50–55.
  • Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 1995;155:3013–3020.
  • Stasi K, Nagel D, Yang X et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci. 2006;47:1024–1029.
  • Kuehn MH, Kim CY, Ostojic J et al. Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp Eye Res. 2006;83:620–628.
  • Tezel G, Yang X, Luo C et al. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci. 2010;51:5071–5082.
  • Stevens B, Allen NJ, Vazquez LE et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164–1178.
  • Kuehn MH, Kim CY, Jiang B, Dumitrescu AV, Kwon YH. Disruption of the complement cascade delays retinal ganglion cell death following retinal ischemia-reperfusion. Exp Eye Res. 2008;87:89–95.
  • Miyahara T, Kikuchi T, Akimoto M, Kurokawa T, Shibuki H, Yoshimura N. Gene microarray analysis of experimental glaucomatous retina from cynomologous monkey. Invest Ophthalmol Vis Sci. 2003;44:4347–4356.
  • Steffensen R, Hoffmann K, Varming K. Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes. J Immunol Methods. 2003;278:191–199.
  • Wax MB, Tezel G. Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res. 2009;88:825–830.
  • Tezel G, Hernandez R, Wax MB. Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch Ophthalmol. 2000;118:511–518.
  • Maruyama I, Ohguro H, Ikeda Y. Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest Ophthalmol Vis Sci. 2000;41:1657–1665.
  • Yang J, Tezel G, Patil RV, Romano C, Wax MB. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci. 2001;42:1273–1276.
  • Ikeda Y, Maruyama I, Nakazawa M, Ohguro H. Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients. Jpn J Ophthalmol. 2002;46:13–17.
  • Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol. 1999;117:917–924.
  • Howell GR, Macalinao DG, Sousa GL et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011;121:1429–1444.
  • Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology. 1998;199:327–339.
  • Santos IK, Costa CH, Krieger H et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun. 2001;69:5212–5215.
  • Bax WA, Cluysenaer OJ, Bartelink AK, Aerts PC, Ezekowitz RA, van Dijk H. Association of familial deficiency of mannose-binding lectin and meningococcal disease. Lancet. 1999;354:1094–1095.
  • Hegele RA, Ban MR, Anderson CM, Spence JD. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Investig Med. 2000;48:198–202.
  • Kilpatrick DC. Mannan-binding lectin and its role in innate immunity. Transfus Med. 2002;12:335–352.
  • Gupta K, Gupta RK, Hajela K. Disease associations of mannose-binding lectin & potential of replacement therapy. Indian J Med Res. 2008;127:431–440.
  • Davies EJ, Snowden N, Hillarby MC et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum. 1995;38:110–114.
  • Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum. 1998;41:1663–1668.
  • Garred P, Madsen HO, Halberg P et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 1999;42:2145–2152.
  • Øhlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med. 2004;351:260–267.
  • Graudal NA, Homann C, Madsen HO et al. Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol. 1998;25:629–635.
  • Kruse C, Rosgaard A, Steffensen R, Varming K, Jensenius JC, Christiansen OB. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol. 2002;187:1313–1320.
  • Annells MF, Hart PH, Mullighan CG et al. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth. Am J Obstet Gynecol. 2004;191:2056–2067.
  • Saevarsdottir S, Oskarsson OO, Aspelund T et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med. 2005;201:117–125.
  • Ma Y, Uemura K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: Mannan-binding proteindependent cell-mediated cytotoxicity. Proc Natl Acad Sci USA. 1999;96:371–375.
  • Santos IK, Costa CH, Krieger H, et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun. 2001;69:5212–5215.
  • Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. Dual role of mannan-binding protein in infections: Another case of heterosis? Eur J Immunogenet. 1994;21:125–131.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.